1Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ,2000,321 (7264): 794-796.
2Baron R. Peripheral neuropathic pain: from mechanisms to symptoms.Clin J Pain, 2000 , 16(2 Suppl): S12-20.
3Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl, 1999,173: 25-35.
4Chiarello SE. Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol, 1998 , 134(3) :279-281.
5Matarasso SL. Update on the aesthetic uses of botulinum-A neurotoxin in facial rejuvenation. Curr Probl Dermatol,2001,13 :46-53.
6Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol,2000,43(2 Pt 1 ) :249-259.
7Khawaja HA, Hernandez -Perez E. Botox in dermatology. Int J Dermatol,2001,40(5) :311-317.
8Sugeng MW.Yosipovitch G.Leok GC.Post herpetic neurallgia and the dermatologist.Int J Demmatol.2001.40(1):6-11.
9Johnson RW.Prevention of post-berpetic neuralgia:can it be achieved?Acta Anaesthesiol Scand.2000.44(8):903-905.
10Cunningham AL.Dworkin RH.The management of post-herpetic neuralgia BMJ.2000.321(7264):778-779.
